The role of immunophenotypic markers in the classification of non-Hodgkin's lymphomas

Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.

Leukemia·2016

Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Annals of oncology : official journal of the European Society for Medical Oncology·2009

Stromal gene signatures in large-B-cell lymphomas.

The New England journal of medicine·2008

Light-chain-restricted germinal centres in reactive lymphadenitis: report of eight cases.

Histopathology·2008

Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.

Leukemia·2007

Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Histopathology·2002

Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy.

Seminars in oncology·2026

Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions.

Seminars in oncology·2026

Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.

Seminars in oncology·2026

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Seminars in oncology·2026

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

Seminars in oncology·2026

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Seminars in oncology·2026

The soluble HLA repertoire captures neoantigenic, cryptic, and tumour-associated peptides in melanoma.

Molecular & cellular proteomics : MCP·2026

Inflammatory Breast Cancer-The Evolution of Diagnosis and Modern Clinical Management.

JCO oncology practice·2026

Engineering Subcutaneous Ectopic Tertiary Lymphoid Structures as Personalized Immune-Activation Niches for Cancer Immunotherapy.

ACS applied bio materials·2026

Exosomes derived from itaconate-treated macrophages promote epithelial-mesenchymal transition, migration, and invasion in MCF-7 breast cancer cells.

Medical oncology (Northwood, London, England)·2026

Vibostolimab Coformulated with Pembrolizumab Plus Chemotherapy as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer.

Targeted oncology·2026

Tumor-Associated Mast Cells Drive Immunosuppression and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma Through CCL17/CCR4-mediated Regulatory T-Cell Recruitment.

Journal of biochemical and molecular toxicology·2026

Related Experiment Videos

The role of immunophenotypic markers in the classification of non-Hodgkin's lymphomas

Related Concept Videos

Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.

Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Stromal gene signatures in large-B-cell lymphomas.

Light-chain-restricted germinal centres in reactive lymphadenitis: report of eight cases.

Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.

Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy.

Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions.

Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

The soluble HLA repertoire captures neoantigenic, cryptic, and tumour-associated peptides in melanoma.

Inflammatory Breast Cancer-The Evolution of Diagnosis and Modern Clinical Management.

Engineering Subcutaneous Ectopic Tertiary Lymphoid Structures as Personalized Immune-Activation Niches for Cancer Immunotherapy.

Exosomes derived from itaconate-treated macrophages promote epithelial-mesenchymal transition, migration, and invasion in MCF-7 breast cancer cells.

Vibostolimab Coformulated with Pembrolizumab Plus Chemotherapy as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer.

Tumor-Associated Mast Cells Drive Immunosuppression and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma Through CCL17/CCR4-mediated Regulatory T-Cell Recruitment.

Related Experiment Videos

The role of immunophenotypic markers in the classification of non-Hodgkin's lymphomas

Related Concept Videos

Related Articles